ADDF-funded investigators to present research on wide range of novel approaches that will support a combination therapy and precision medicine approach NEW YORK, Oct. 17, 2023 /PRNewswire/ The Alzheimer's Drug Discovery Foundation (ADDF) will be moderating a session, "Emerging Solutions: Novel Approaches to Treating Alzheimer's Disease," at the 2023 Clinical Trials on Alzheimer's Disease (CTAD) conference, which will be held October 24th through 27th at Boston Park Plaza in Boston,